4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001331
Director sold 4,500 shares at an average $64.72 ($291,244)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waddill William D. Director | 2022-01-03 | Sale | −2,100 | $64.23 | $134,883 | 28,150 | D: show line 1 in the form |
| Waddill William D. Director | 2022-01-03 | Sale | −2,128 | $65.01 | $138,341 | 26,022 | D: show line 2 in the form |
| Waddill William D. Director | 2022-01-03 | Sale | −272 | $66.25 | $18,020 | 25,750 | D: show line 3 in the form |
| Open-market sales · 4,500 sh · avg $64.72 · $291,244 | |||||||
Loading xslF345X03/doc4.xml…